Literature DB >> 8227415

Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas.

L C Wijnaendts1, J C van der Linden, P van Diest, A J van Unnik, J F Delemarre, P A Voûte, C J Meijer.   

Abstract

AIM: To determine whether DNA ploidy patterns and S phase fraction offer prognostic information in patients with rhabdomyosarcoma (RMS).
METHODS: DNA flow cytometry was performed on formalin fixed, paraffin wax embedded samples from primary tumours, and metastatic deposits or recurrences in 70 patients. DNA histogram analysis was done using a semi-automated cell cycle analysis program.
RESULTS: Of the 70 primary tumours, 23 were DNA diploid, 32 DNA aneuploid, eight DNA multiploid, and seven DNA tetraploid. The prognosis for DNA aneuploid patterns was favourable, intermediate within the group of DNA tetraploid tumours and poor among patients with DNA diploid and DNA multiploid tumours (p = 0.009). In multivariate analysis (Cox regression model) DNA ploidy was an important independent prognostic factor, along with TNM stage, localisation, and histopathological classification. Ten out of 32 patients with a high S phase fraction (> 15%) with primary RMS achieved long term survival in contrast to 20 out of 29 patients with a low S phase fraction (< or = 15%) (p = 0.008). In 24 cases the DNA ploidy of cases of relapse was analysed. Of the 15 cases, in which stem line changes had occurred, 13 died of disease. No stem line changes were noted in nine cases and in this group four patients died of disease (p = 0.02).
CONCLUSIONS: Assessment of DNA ploidy and S phase fraction in primary RMS and evaluation of stem line changes in cases of relapse are important variables in predicting prognosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227415      PMCID: PMC501625          DOI: 10.1136/jcp.46.10.948

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  30 in total

Review 1.  Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs.

Authors:  V Ling
Journal:  Cancer       Date:  1992-05-15       Impact factor: 6.860

2.  Prognostic factors in 281 children with nonmetastatic rhabdomyosarcoma (RMS) at diagnosis.

Authors:  C Rodary; A Rey; D Olive; F Flamant; E Quintana; M Brunat-Mentigny; J Otten; P A Voute
Journal:  Med Pediatr Oncol       Date:  1988

3.  Chromosomal analysis of sixteen human rhabdomyosarcomas.

Authors:  S Wang-Wuu; S Soukup; E Ballard; B Gotwals; B Lampkin
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

4.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.

Authors:  G M Clark; L G Dressler; M A Owens; G Pounds; T Oldaker; W L McGuire
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

5.  Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping.

Authors:  H J Scrable; D P Witte; B C Lampkin; W K Cavenee
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

6.  DNA-aneuploidy in rhabdomyosarcomas as compared with other sarcomas of childhood and adolescence.

Authors:  W M Molenaar; A Dam-Meiring; W A Kamps; C J Cornelisse
Journal:  Hum Pathol       Date:  1988-05       Impact factor: 3.466

7.  Embryonal rhabdomyosarcoma of bladder and prostate: nuclear DNA patterns studied by flow cytometry.

Authors:  E T Boyle; H M Reiman; S A Kramer; P P Kelalis; L M Rainwater; M M Lieber
Journal:  J Urol       Date:  1988-11       Impact factor: 7.450

8.  Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II).

Authors:  W Lawrence; E A Gehan; D M Hays; M Beltangady; H M Maurer
Journal:  J Clin Oncol       Date:  1987-01       Impact factor: 44.544

Review 9.  DNA flow cytometry in solid tumors: practical aspects and clinical applications.

Authors:  L G Dressler; S A Bartow
Journal:  Semin Diagn Pathol       Date:  1989-02       Impact factor: 3.464

10.  Prognostic implication of cellular DNA content in acute lymphoblastic leukemia.

Authors:  M Tsurusawa; N Katano; S Kawai; T Fujimoto; M Maeda
Journal:  Am J Pediatr Hematol Oncol       Date:  1988
View more
  4 in total

1.  Gallbladder cancer. A comparative study among clinicopathologic features, AgNORs, and DNA content analysis.

Authors:  J E Nishizawa-Takano; H Ayabe; K Hatano; H Yamaguchi; Y Tagawa
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

2.  Peripheral primitive neuroectodermal tumour and extra-osseous Ewing's sarcoma; a histological, immunohistochemical and DNA flow cytometric study.

Authors:  M Brinkhuis; L C Wijnaendts; J C van der Linden; A J van Unnik; P A Voûte; J P Baak; C J Meijer
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Prognostic Value of Microvessel Density in Tumor and Peritumoral Area as Evaluated by CD31 Protein Expression and Argyrophilic Nucleolar Organizer Region Count in Endothelial Cells in Uterine Leiomyosarcoma.

Authors:  Ashot Avdalyan; Igor Bobrov; Vladimir Klimachev; Alexander Lazarev
Journal:  Sarcoma       Date:  2012-07-15

4.  The clinical value of flow cytometric DNA content analysis in patients with soft tissue sarcomas.

Authors:  M Samur; A Pamir; H Akbulut; S Erekul; Y Sağlik; Y Yildiz; D Dinçol; F Içli
Journal:  Sarcoma       Date:  1999
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.